Trial Details
RECRUITINGBasic Information
| Clinical ID | c873 |
|---|---|
| Identifier | NCT05906576 |
| Trial Title | Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Infliximab |
Participant Information
| Sponsor | Taizhou Mabtech Pharmaceutical Co.,Ltd |
|---|---|
| City | Beijing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2023-09-21 |
|---|---|
| Primary Completion Date | 2026-11 |
| Completion Date | 2027-02 |